Astellas Pharma Inc. (TYO:4503)

Japan · Delayed Price · Currency is JPY

2,347.50

-14.00 (-0.59%)

At close: Mar 16, 2026

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical	1.91T	1.60T	1.52T	1.30T	1.25T
Pharmaceutical Growth	19.25%	5.60%	17.16%	3.73%	-3.94%
Total	1.91T	1.60T	1.52T	1.30T	1.25T
Total Growth	19.25%	5.60%	17.16%	3.73%	-3.94%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Japan	280.11B	286.22B	284.84B	268.94B	297.23B
Japan Growth	-2.14%	0.48%	5.91%	-9.52%	-20.78%
USA	871.90B	668.55B	658.25B	544.10B	478.77B
USA Growth	30.42%	1.57%	20.98%	13.65%	6.85%
Others	760.31B	648.90B	575.53B	483.12B	473.53B
Others Growth	17.17%	12.75%	19.13%	2.03%	-0.85%
Total	1.91T	1.60T	1.52T	1.30T	1.25T
Total Growth	19.25%	5.60%	17.16%	3.73%	-3.94%

Source: S&P Global Market Intelligence.